BioPharmaTrend
Latest Insights
Companies
  • Companies Directory
  • Case Studies
Newsletter
About
  • At a Glance
  • Our Team
  • Advisory Board
  • Citations and Press Coverage
  • Partner Events Calendar
  • Advertise with Us
 
 Subscribe 
Sign in
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools
  • Business Intelligence
Back to Companies Directory

ProQR Therapeutics

ProQR Therapeutics logo

Website
https://www.proqr.com/
Founded
2012

Technologies

Antisense Oligonucleotides RNA-focused Startups

ProQR Therapeutics is a Leiden, NL based biotech company focused on developments of drugs to treat genetic disorders using ADAR enzymes to edit RNA. Based on a novel proprietary technology we discover and develop drugs to change the lives of patients around the world. Founded by industry icons and based on groundbreaking science we strive to make a meaningful impact.


Articles Mentioning This Company

Antisense Oligonucleotides Make Sense

July 28, 2021     Articles
Antisense oligonucleotides (ASOs) are short (about 12 to 25 nucleotides long), synthetic single strands of DNA or RNA that are complementary to a chosen sequence. They can alter RNA and reduce, restore, or modify protein expression. ASOs interact with proteins on the surface of cells and enter the cytoplasm. Then …

BiopharmaTrend.com

Where Tech Meets Bio
mail  Newsletter
in  LinkedIn
x  X
rss  RSS Feed

About


  • What we do
  • Press & Citations
  • Terms of Use
  • Privacy Policy
  • Cookies Policy
  • Disclaimer

Topics


  • News
  • AI in Bio
  • Tech Giants
  • Next-Gen Tools

Explore


  • Premium Insights
  • Business Intelligence
  • Companies
  • Events
  • Authors

Partner


  • Sponsorship
  • Editorial Calendar

© WTMB Research & Media, S.L. (WTMB Group)   2026
We use cookies to personalise content and to analyse our traffic. You consent to our cookies if you continue to use our website. Read more details in our cookies policy.